CTAD: Sigma-1 receptor agonist passes muster in small Alzheimer’s trial

BARCELONA – A novel small molecule that may help clear misfolded proteins imparted some significant cognitive benefits to Alzheimer’s patients after 5 weeks, even with a mid-study washout period in...